Table 2.
Clinical characteristics of participants with lupus.
|
|
|
n (%)a or mean (SD) | |
| Disease duration (y), mean (SD) |
|
10.2 (9.5) | |
| Disease activityb , mean (SD) |
|
4.4 (2.8) | |
| Global assessment (n=634), n (%) |
|
||
|
|
Poor | 58 (9.1) | |
|
|
Fair | 208 (32.8) | |
|
|
Good | 236 (37.2) | |
|
|
Very good | 113 (17.8) | |
|
|
Excellent | 19 (3.0) | |
| PHQ-2 score (n=612), mean (SD) | 1.9 (1.8) | ||
|
|
Screened positive for depressionc , n (%) |
|
172 (28.1) |
| PSS-4 score (n=610), mean (SD) | 6.9 (3.1) | ||
|
|
Screened positive for moderate to severe stressd , n (%) |
|
291 (47.7) |
aTo adjust for missing values, percentages were calculated using non-missing values
bDisease activity was scored on a 10-point visual analog scale (0=no activity; 10=most activity)
cPHQ-2 score ≥3 indicates depression
dScores in 4th and 5th quintiles on PSS-4 indicate moderate and high stress, respectively; PHQ-2: Patient Health Questionnaire-2; PSS-4: Perceived Stress Scale-4 (PSS-4)